May 30, 2026 to June 3, 2026
Henry Cheng International Conference Centre
Asia/Hong_Kong timezone

HNF1A-AS1: A Novel Regulator of PXR Phase Separation and Drug Metabolism

Not scheduled
20m
Henry Cheng International Conference Centre

Henry Cheng International Conference Centre

Nuclear Receptors & Noncoding RNAs in Drug Metabolism

Speaker

Ms Yaping Bi (Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou University, Zhengzhou 450001, China)

Description

Abstract
Background:
The induction of cytochrome P450 3A4 (CYP3A4) mediates critical drug-drug interactions and variability in drug response. While ligand-activated PXR drives CYP3A4 transcription, the mechanism enabling efficient transcriptional complex assembly remains unclear. This study investigates whether the long non-coding RNA HNF1A-AS1 regulates this process by promoting PXR liquid-liquid phase separation (LLPS).
Methods:
In HepG2 cells stimulated with rifampicin (RIF), RNAscope and immunofluorescence were used to assess PXR and HNF1A-AS1 co-localization. PXR intrinsically disordered regions (IDRs) were predicted and deletion mutants constructed. PXR phase separation was analyzed via live cell imaging and fluorescence recovery after photobleaching (FRAP). Gain- and loss-of-function experiments assessed HNF1A-AS1's role in condensate formation.
Results:
RIF promoted nuclear co-localization of PXR with HNF1A-AS1 and induced dynamic PXR condensates. Deletion of PXR IDRs abolished this process. These condensates exhibited liquid-like properties, including fusion and rapid fluorescence recovery. Importantly, HNF1A-AS1 overexpression enhanced, while its knockdown suppressed, RIF-induced PXR condensate formation.
Conclusions:
Our findings establish HNF1A-AS1 as a key RNA scaffold that facilitates PXR LLPS and the assembly of transcriptionally active condensates, thereby enabling efficient CYP3A4 induction. The HNF1A-AS1-PXR axis represents a novel potential target for predicting and managing drug interactions and toxicity.
Key words: HNF1A-AS1; PXR; Liquid-liquid phase separation; CYP3A4; Drug metabolism
Acknowledgments: Supported by NSFC (No. 82373947).

Author

Ms Yaping Bi (Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou University, Zhengzhou 450001, China)

Co-authors

Prof. Lirong Zhang (Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou University, Zhengzhou 450001, China) Dr Yiting Wang (Department of Clinical Pharmacology, School of Medicine, Henan University of Chinese Medicine, 450046 Zhengzhou, China)

Presentation materials

There are no materials yet.